| __timestamp | Arrowhead Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 40786000 |
| Thursday, January 1, 2015 | 34718089 | 47876000 |
| Friday, January 1, 2016 | 40998209 | 52035000 |
| Sunday, January 1, 2017 | 32022880 | 55348000 |
| Monday, January 1, 2018 | 19110051 | 65276000 |
| Tuesday, January 1, 2019 | 26556257 | 82720000 |
| Wednesday, January 1, 2020 | 52275890 | 89118000 |
| Friday, January 1, 2021 | 80981000 | 181193000 |
| Saturday, January 1, 2022 | 124431000 | 174078000 |
| Sunday, January 1, 2023 | 90932000 | 184232000 |
| Monday, January 1, 2024 | 98761000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, understanding operational efficiency is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Veracyte, Inc. and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Veracyte's SG&A expenses surged by approximately 350%, peaking in 2023. In contrast, Arrowhead's expenses increased by about 300%, with a notable spike in 2022. This trend highlights Veracyte's aggressive expansion strategy, as it consistently outspent Arrowhead, especially in 2021, where its expenses were nearly double. However, 2024 data for Veracyte is missing, leaving room for speculation on its current trajectory. These insights underscore the importance of strategic spending in maintaining competitive advantage in the biotech sector. As both companies continue to innovate, their SG&A efficiency will be pivotal in shaping their future success.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Alnylam Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Genmab A/S vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Sarepta Therapeutics, Inc. vs Veracyte, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Alkermes plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and Mesoblast Limited
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE